4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Pulmatrix, Inc. (PULM) operates in the Biotechnology industry and is headquartered in Framingham, United States with about 2 employees. Its market capitalization is roughly $7 million. In the fiscal year ended 2025-12-31, PULM reported $0M in revenue and ($5M) in net income.
Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $8M | $7M | $6M | — |
| Operating Income (EBIT) | ($5M) | ($7M) | ($15M) | ($19M) | — |
| Net Income | ($5M) | ($10M) | ($14M) | ($19M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($1M) | ($1M) | ($1M) | ($2M) | ($2M) | — |
| Net Income | ($1M) | ($1M) | ($1M) | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $4M | $10M | $34M | $41M | — |
| Total Liabilities | $0M | $1M | $16M | $10M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PULM viewer.
About TickerBase · Data methodology & sources